Inga Margrethe Ulste Loen
Plus aucun poste en cours
Fortune : 307 902 $ au 30/04/2024
Profil
Inga Margrethe Ulste Loen worked as a Director at Algeta ASA.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BYGGMA ASA
0,25% | 15/02/2024 | 175 760 ( 0,25% ) | 307 902 $ | 30/04/2024 |
Anciens postes connus de Inga Margrethe Ulste Loen
| Sociétés | Poste | Fin |
|---|---|---|
| ALGETA ASA | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |